However, we suggest that opposite effect of EZH2 expression and EZH2 inhibitor might cause NASH model difference between HFa/HFr-D induced NAFLD and streptozotocin (STZ)/high-fat induced NASH model. Here, EZH2 is linked to metabolic dysfunction-associated steatohepatitis.